Status:
RECRUITING
Evaluating Alcohol Use in Alcoholic Liver Disease
Lead Sponsor:
Nicole T Shen
Conditions:
Alcoholic Liver Disease
Eligibility:
All Genders
18-80 years
Brief Summary
This prospective, analytic observational study will investigate alcohol recidivism in patients with alcoholic liver disease. All adult subjects presenting with alcoholic liver disease are considered f...
Detailed Description
This is a longitudinal observational study. Subjects with a diagnosis of alcoholic liver disease (acute alcoholic hepatitis or alcoholic cirrhosis) who present to Weill Cornell Medical Center or Colum...
Eligibility Criteria
Inclusion
- alcoholic liver disease able to consent
Exclusion
- without alcoholic liver disease unable to consent
Key Trial Info
Start Date :
November 27 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2027
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT03267069
Start Date
November 27 2016
End Date
November 1 2027
Last Update
March 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York Presbyterian Hospital - Weill Cornell Medicine and Columbia University Medical Center
New York, New York, United States, 10021